12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet

RxCUI: 1046770
RxNorm name: 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
Display name: Hyoscyamine XR (Oral Pill)
Full name: 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet
Term type: SCD
Status: Active
Strength: 0.375 mg
Dose form: 12 HR XR Tab
Route: Oral Pill
Updated: 2026-08-03 17:29:10

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 122010
Active start: 122010
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
hyoscyamine sulfate	0.375 MG / 1 EACH	hyoscyamine	hyoscyamine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Extended Release Oral Tablet	316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
hyoscyamine	153970

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet	1	NAMES
RxNorm Name	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet	1	NAMES
RxNorm Synonym	2 linked values hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet	2	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	6 linked values 01f97804-a6cb-ce6d-e063-6394a90ae220 5bbce8c0-a9c9-45b9-8457-1542bd3d9449 342edf8e-cca5-4018-9373-0b2e62bc9f4b 3859133e-88bd-4dd5-90a0-82b64347f1db b12f856f-7157-4aee-bf73-1fdcb4834ffc d7189f97-d570-4662-8f1d-cf1da02f01ec	6	CODES
RxCUI	1046770	1	CODES
MMSL_CODE	2 linked values BD5269 CD5269	2	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler
16477-738-01	16477-738	Hyoscyamine Sulfate Hyoscyamine Sulfate	Laser Pharmaceuticals, LLC
39328-052-10	39328-052	Hyoscyamine Sulfate Hyoscyamine Sulfate	Patrin Pharma, Inc.
51525-0115-1	51525-0115	Hyoscyamine hyoscyamine sulfate	Mylan Pharmaceuticals Inc.
62135-860-60	62135-860	Hyoscyamine sulfate Hyoscyamine sulfate	Chartwell RX, LLC
62559-423-01	62559-423	Hyoscyamine Sulfate Hyoscyamine Sulfate	ANI Pharmaceuticals, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 2 of 2 · 144 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
58118001303	rxnav_historical
58118001308	rxnav_historical
58177023704	rxnav_historical
58716067101	rxnav_historical_indirect
58716067201	rxnav_historical_indirect
58716076390	rxnav_historical_indirect
58716092410	rxnav_historical_indirect
58716092450	rxnav_historical_indirect
59879011401	rxnav_historical
60258080301	rxnav_historical
60687010111	rxnav_historical
60687010121	rxnav_historical
62175010801	rxnav_historical
62584001900	rxnav_historical_indirect
64125011001	rxnav_historical
64543011201	rxnav_historical_indirect
64543011202	rxnav_historical_indirect
64543011890	rxnav_historical_indirect
68032025190	rxnav_historical
68047025501	rxnav_historical
68151518200	rxnav_historical
68220011510	rxnav_historical_indirect
68220011550	rxnav_historical_indirect
69189046601	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hyoscyamine Sulfate	HYOSCYAMINE SULFATE	Laser Pharmaceuticals, LLC	b12f856f-7157-4aee-bf73-1fdcb4834ffc	2025-10-17	Warnings, Adverse reactions	Exact identifier ndc (package): 16477-738-01 ndc (product): 16477-738 ndc11 (package): 16477073801 rxcui: 1046770
Hyoscyamine Sulfate	HYOSCYAMINE SULFATE	ANI Pharmaceuticals, Inc.	3859133e-88bd-4dd5-90a0-82b64347f1db	2025-09-12	Warnings, Adverse reactions	Exact identifier ndc (package): 62559-423-01 ndc (product): 62559-423 ndc11 (package): 62559042301 rxcui: 1046770
Levbid	HYOSCYAMINE SULFATE	Viatris Specialty LLC	eb13c96f-319a-46f4-9955-ef5fa0a5f110	2025-07-15	Warnings, Adverse reactions	Exact identifier ndc11 (package): 68220011510 rxcui: 1046770
Hyoscyamine Sulfate	HYOSCYAMINE SULFATE	Patrin Pharma, Inc.	d7189f97-d570-4662-8f1d-cf1da02f01ec	2024-09-03	Warnings, Adverse reactions	Exact identifier ndc (package): 39328-052-10 ndc (product): 39328-052 ndc11 (package): 39328005210 rxcui: 1046770
Hyoscyamine sulfate	HYOSCYAMINE SULFATE	Chartwell RX, LLC	342edf8e-cca5-4018-9373-0b2e62bc9f4b	2024-06-07	Warnings, Adverse reactions	Exact identifier ndc (package): 62135-860-60 ndc (product): 62135-860 ndc11 (package): 62135086060 rxcui: 1046770
Hyoscyamine ER	HYOSCYAMINE SULFATE	Mylan Pharmaceuticals Inc.	5bbce8c0-a9c9-45b9-8457-1542bd3d9449	2023-07-15	Warnings, Adverse reactions	Exact identifier ndc (package): 51525-0115-1 ndc (product): 51525-0115 ndc11 (package): 51525011501 rxcui: 1046770

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
eb13c96f-319a-46f4-9955-ef5fa0a5f110	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	6	Levbid ® (hyoscyamine sulfate, 0.375 mg) extended-release tablets Rx Only 201090-01 115 Rev. 07/2025	20250715
5bbce8c0-a9c9-45b9-8457-1542bd3d9449	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	4	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only	20230715
01f97804-a6cb-ce6d-e063-6394a90ae220	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	3	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only (Packaged by Pharma Packaging Solutions, LLC dba Tjoapack LLC)	20250506
b12f856f-7157-4aee-bf73-1fdcb4834ffc	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	2	Hyoscyamine Sulfate Tablets 0.375 mg Rx Only	20251017
3859133e-88bd-4dd5-90a0-82b64347f1db	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	2	Hyoscyamine Sulfate Extended-Release Tablets	20250912
2bf8d44e-e1b2-4a1d-9914-00bb7ef1293e	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	2	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328	20100217
d7189f97-d570-4662-8f1d-cf1da02f01ec	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	1	Hyoscyamine Sulfate Extended-Release Oral Tablets, 0.375 mg	20240903
342edf8e-cca5-4018-9373-0b2e62bc9f4b	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	1	Hyoscyamine Sulfate Extended-Release Tablets Rx Only	20240607
4c2b85b3-0f7a-4832-9d53-bc026116a1e6	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [SCD] · hyoscyamine sulfate 0.375 MG 12 HR Extended Release Oral Tablet [SY] · hyoscyamine sulfate 375 MCG 12 HR Extended Release Oral Tablet [SY]	4	1	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328	20140105

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
b12f856f-7157-4aee-bf73-1fdcb4834ffc	Hyoscyamine Sulfate Tablets 0.375 mg Rx Only	Laser Pharmaceuticals, LLC	20251017
3859133e-88bd-4dd5-90a0-82b64347f1db	Hyoscyamine Sulfate Extended-Release Tablets	ANI Pharmaceuticals, Inc.	20250912
eb13c96f-319a-46f4-9955-ef5fa0a5f110	Levbid ® (hyoscyamine sulfate, 0.375 mg) extended-release tablets Rx Only 201090-01 115 Rev. 07/2025	Viatris Specialty LLC	20250715
01f97804-a6cb-ce6d-e063-6394a90ae220	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only (Packaged by Pharma Packaging Solutions, LLC dba Tjoapack LLC)	Pharma Packaging Solutions, LLC dba Tjopack LLC \| Sovereign Pharmaceuticals, LLC \| Pharma Packaging Solutions, LLC dba Tjoapack LLC	20250506
d7189f97-d570-4662-8f1d-cf1da02f01ec	Hyoscyamine Sulfate Extended-Release Oral Tablets, 0.375 mg	Patrin Pharma, Inc.	20240903
342edf8e-cca5-4018-9373-0b2e62bc9f4b	Hyoscyamine Sulfate Extended-Release Tablets Rx Only	Chartwell RX, LLC \| Chartwell Pharmaceuticals Congers, LLC	20240607
d02d1b0d-5c40-c5aa-b283-74efd7d1e06b	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg	Alvogen Inc.	20240509
b12f856f-7157-4aee-bf73-1fdcb4834ffc	Hyoscyamine Sulfate Tablets 0.375 mg Rx Only	Laser Pharmaceuticals, LLC	20240129
d1bb2ea1-cde8-4f3b-93b6-04c7a441f453	Symax ® -SR	Capellon Pharmaceuticals, LLC	20230822
0cab4421-d99e-4cd0-8993-e46c484dc3cb	Symax ® Duotab Hyoscyamine Sulfate BIPHASIC TABLETS* Rx Only *U.S. Patent No. 9,308,164	Capellon Pharmaceuticals, LLC	20230821
5bbce8c0-a9c9-45b9-8457-1542bd3d9449	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only	Mylan Pharmaceuticals Inc.	20230715
d2b55db1-be5f-4fe0-b31d-21bbe85a34f1	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328	County Line Pharmaceuticals, LLC	20220915
5361160c-c979-4a4f-8a46-fcf85560c967	OSCIMIN SR Tablets	Larken Laboratories, Inc.	20211018
7344cb82-1d5a-43ff-860a-21d5aac008e2	Hyoscyamine Sulfate Sustained Release Tablets	KMR Pharmaceuticals LLC	20150727
4c2b85b3-0f7a-4832-9d53-bc026116a1e6	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328	Aidarex Pharmaceuticals LLC	20140105
6e69aa1e-468b-445e-96e9-7334de7ae29a		National Council for Prescription Drug Programs	20130213
c89737d4-383c-4c44-8c24-dd5dea8cfb86		National Council for Prescription Drug Programs	20130213
d0d4807b-a0da-4345-8538-23b9851807b8		National Council for Prescription Drug Programs	20120724
eb60f1b7-f6dc-4959-9617-7f7ef5eecde6		National Council for Prescription Drug Programs	20120724
b2aeef34-7f7d-43e4-a7d5-b294d880c279		National Council for Prescription Drug Programs	20120724
a44f0c7a-69fc-440e-94bf-4b992df5b15c		National Council for Prescription Drug Programs	20120724
81592484-e838-4021-bed3-336b573f4066		National Council for Prescription Drug Programs	20120724
69165d39-1d76-4706-9e35-3cd37a4d2fd9		National Council for Prescription Drug Programs	20120724
352e6855-b146-4a20-a06e-77e5efc51dff		National Council for Prescription Drug Programs	20120724
3a200492-c460-4b19-ac16-b64493904b88	Hyoscyamine Sulfate Extended-Release Tablets, USP 0.375 mg	Franklin Pharmaceutical LLC \| Sovereign Pharmaceuticals Ltd \| Carton Services Inc	20100408
2bf8d44e-e1b2-4a1d-9914-00bb7ef1293e	Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg PI-9328	Carilion Materials Management	20100217

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	A03BA	Belladonna alkaloids, tertiary amines	ATC1-4		hyoscyamine
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine sulfate
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine sulfate
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine sulfate
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Levbid	rxnav_allrelated
BN	BN	Oscimin	rxnav_allrelated
BN	BN	Symax	rxnav_allrelated
DF	DF	Extended Release Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	hyoscyamine	rxnav_allrelated
PIN	PIN	hyoscyamine sulfate	rxnav_allrelated
SBD	SBD	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid]	rxnav_allrelated
SBD	SBD	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Oscimin]	rxnav_allrelated
SBD	SBD	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Symax]	rxnav_allrelated
SBDC	SBDC	hyoscyamine sulfate 0.375 MG [Levbid]	rxnav_allrelated
SBDC	SBDC	hyoscyamine sulfate 0.375 MG [Oscimin]	rxnav_allrelated
SBDC	SBDC	hyoscyamine sulfate 0.375 MG [Symax]	rxnav_allrelated
SBDF	SBDF	hyoscyamine Extended Release Oral Tablet [Levbid]	rxnav_allrelated
SBDF	SBDF	hyoscyamine Extended Release Oral Tablet [Oscimin]	rxnav_allrelated
SBDF	SBDF	hyoscyamine Extended Release Oral Tablet [Symax]	rxnav_allrelated
SBDFP	SBDFP	hyoscyamine sulfate Extended Release Oral Tablet [Levbid]	rxnav_allrelated
SBDFP	SBDFP	hyoscyamine sulfate Extended Release Oral Tablet [Oscimin]	rxnav_allrelated
SBDFP	SBDFP	hyoscyamine sulfate Extended Release Oral Tablet [Symax]	rxnav_allrelated
SBDG	SBDG	Levbid Oral Product	rxnav_allrelated
SBDG	SBDG	Levbid Pill	rxnav_allrelated
SBDG	SBDG	Oscimin Oral Product	rxnav_allrelated
SBDG	SBDG	Oscimin Pill	rxnav_allrelated
SBDG	SBDG	Symax Oral Product	rxnav_allrelated
SBDG	SBDG	Symax Pill	rxnav_allrelated
SCD	SCD	12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet	rxnav_allrelated
SCDC	SCDC	hyoscyamine sulfate 0.375 MG	rxnav_allrelated
SCDF	SCDF	hyoscyamine Extended Release Oral Tablet	rxnav_allrelated
SCDFP	SCDFP	hyoscyamine sulfate Extended Release Oral Tablet	rxnav_allrelated
SCDG	SCDG	hyoscyamine Oral Product	rxnav_allrelated
SCDG	SCDG	hyoscyamine Pill	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate Oral Product	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.375 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	12 HR
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	VUID	4006721
NAMES	Prescribable Synonym	hyoscyamine sulfate 0.375 MG 12HR Extended Release Oral Tablet
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File